Basic Information
RNALocate ID: | RLID:11000868 |
RNA Symbol: | hsa-miR-26b-5p |
Localization: | Extracellular vesicle |
RNA Information
RNA Name: | hsa-miR-26b |
RNA ID: | miRBase:MIMAT0000083 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 22849433 |
Tissue/Cell Line: | HEK-293T cells |
Method: | Next-generation RNA sequencing |
Description: | The total numbers of reads >15 bp matching each miRNA were calculated. These values were then normalized to number of reads per million mapped (RPMM) in each library, to enable direct comparison of expression levels. As a measure of the relative levels of expression of individual miRNAs in cells and EVs, the log (base two) of the ratio of the read number in EVs over that in cells was calculated (log2 (EV/cell)). The miRNA expression data for cells and EVs is presented in Additional file 1: Table S1. Data are collected from Table S1. |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01001357 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001358 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
RLID:01001359 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001360 | Nucleus | Colon adenocarcinoma cells | 20864815 |
RLID:11000861 | Exosome | Hepatocellular carcinoma cell line (HepG2)|Lung epithelial carcinoma cell line (A549) | 20615901 |
RLID:11000862 | Exosome | Breast cancer cell line (MCF-7) | 20976003 |
RLID:11000863 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
RLID:11000864 | Exosome | Renal cancer cells | 21670082 |
RLID:11000865 | Exosome | Breast milk | 22211110 |
RLID:11000866 | Exosome | Brain tissue | 23382797 |
RLID:11000867 | Exosome | Plasma | 23663360 |
RLID:11000869 | Microvesicle | Hepatocellular carcinoma cell line (HepG2)|Lung epithelial carcinoma cell line (A549) | 20615901 |
RLID:11000870 | Microvesicle | Plasma | 23077538 |
RLID:11000871 | Microvesicle | Seminal plasma | 23539611 |
RLID-D:11000019 | Exosome | Blood|B lymphoblastoid cells|Breast milk|Chronic lymphocytic leukemia cells|Colon tissue|Endothelial cells|Epithelial cells|Lymphoma tissue|Mast cells|Seminal fluid|Tongue tissue | |
RLID-D:11000282 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-26b-5p | Diffuse large b cell lymphoma | MNDR-E-MI-33339 |
MNDR | hsa-miR-26b-5p | Splenic marginal zone lymphoma | MNDR-E-MI-33340 |
MNDR | hsa-miR-26b-5p | Oral squamous cell carcinoma | MNDR-E-MI-33341 |
MNDR | hsa-miR-26b-5p | Large cell neuroendocrine cancer | MNDR-E-MI-33342 |
MNDR | hsa-miR-26b-5p | Medulloblastoma | MNDR-E-MI-33343 |
MNDR | hsa-miR-26b-5p | B cell lymphoma of malt type | MNDR-E-MI-33344 |
MNDR | hsa-miR-26b-5p | Ovarian clear cell carcinoma | MNDR-E-MI-33345 |
MNDR | hsa-miR-26b-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-33346 |
MNDR | hsa-miR-26b-5p | Lymphoma | MNDR-E-MI-33347 |
MNDR | hsa-miR-26b-5p | Lymphoma non-hodgkin | MNDR-E-MI-33348 |
MNDR | hsa-miR-26b-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-33349 |
MNDR | hsa-miR-26b-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-33350 |
MNDR | hsa-miR-26b-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-33351 |
MNDR | hsa-miR-26b-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-33352 |
MNDR | hsa-miR-26b-5p | Breast cancer luminal | MNDR-E-MI-33353 |
MNDR | hsa-miR-26b-5p | Niemann-pick disease type c | MNDR-E-MI-33354 |
MNDR | hsa-miR-26b-5p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-33355 |
MNDR | hsa-miR-26b-5p | B cell acute lymphoblastic leukemia | MNDR-E-MI-33356 |
MNDR | hsa-miR-26b-5p | Dermatomyositis | MNDR-E-MI-33357 |
MNDR | hsa-miR-26b-5p | Prostate cancer | MNDR-E-MI-33358 |
MNDR | hsa-miR-26b-5p | Gastric cancer | MNDR-E-MI-33359 |
MNDR | hsa-miR-26b-5p | Gastric lymphoma | MNDR-E-MI-33360 |
MNDR | hsa-miR-26b-5p | Alzheimer disease | MNDR-E-MI-33361 |
MNDR | hsa-miR-26b-5p | Intracranial aneurysm | MNDR-E-MI-33362 |
MNDR | hsa-miR-26b-5p | Urinary bladder cancer | MNDR-E-MI-33363 |
MNDR | hsa-miR-26b-5p | Esophageal carcinoma | MNDR-E-MI-33364 |
MNDR | hsa-miR-26b-5p | Dysautonomia familial | MNDR-E-MI-33365 |
MNDR | hsa-miR-26b-5p | Head and neck cancer | MNDR-E-MI-33366 |
MNDR | hsa-miR-26b-5p | Lewy body dementia | MNDR-E-MI-33367 |
MNDR | hsa-miR-26b-5p | Leukemia | MNDR-E-MI-33368 |
MNDR | hsa-miR-26b-5p | Cardiovascular disease | MNDR-E-MI-33369 |
MNDR | hsa-miR-26b-5p | Lung cancer | MNDR-E-MI-33370 |
MNDR | hsa-miR-26b-5p | Parkinson disease | MNDR-E-MI-33371 |
MNDR | hsa-miR-26b-5p | Niemann-pick disease | MNDR-E-MI-33372 |
MNDR | hsa-miR-26b-5p | Breast cancer | MNDR-E-MI-33373 |
MNDR | hsa-miR-26b-5p | Pituitary neoplasms | MNDR-E-MI-33374 |
MNDR | hsa-miR-26b-5p | Pancreatic cancer | MNDR-E-MI-33375 |
MNDR | hsa-miR-26b-5p | Melanoma | MNDR-E-MI-33376 |
MNDR | hsa-miR-26b-5p | Rectum adenocarcinoma | MNDR-E-MI-33377 |
MNDR | hsa-miR-26b-5p | Nephroblastoma | MNDR-E-MI-33378 |
MNDR | hsa-miR-26b-5p | Colon cancer | MNDR-E-MI-33379 |
MNDR | hsa-miR-26b-5p | Colon adenocarcinoma | MNDR-E-MI-33380 |
MNDR | hsa-miR-26b-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-33381 |
MNDR | hsa-miR-26b-5p | Ovarian cancer | MNDR-E-MI-33382 |
MNDR | hsa-miR-26b-5p | Prostate adenocarcinoma | MNDR-E-MI-33383 |
MNDR | hsa-miR-26b-5p | Laryngeal carcinoma | MNDR-E-MI-33384 |
MNDR | hsa-miR-26b-5p | Kidney cancer | MNDR-E-MI-33385 |
MNDR | hsa-miR-26b-5p | Glioblastoma | MNDR-E-MI-33386 |
MNDR | hsa-miR-26b-5p | Glioma | MNDR-E-MI-33387 |
MNDR | hsa-miR-26b-5p | Oligodendroglioma | MNDR-E-MI-33388 |
MNDR | hsa-miR-26b-5p | Central nervous system lymphoma | MNDR-E-MI-33389 |
MNDR | hsa-miR-26b-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-33390 |
MNDR | hsa-miR-26b-5p | Epilepsy temporal lobe | MNDR-E-MI-33391 |
MNDR | hsa-miR-26b-5p | Osteosarcoma | MNDR-E-MI-33392 |
MNDR | hsa-miR-26b-5p | Inclusion body myositis | MNDR-E-MI-33393 |
MNDR | hsa-miR-26b-5p | Meningioma | MNDR-E-MI-33394 |
MNDR | hsa-miR-26b-5p | Liver cancer | MNDR-E-MI-33395 |
MNDR | hsa-miR-26b-5p | Cervical adenocarcinoma | MNDR-E-MI-33396 |
MNDR | hsa-miR-26b-5p | Gastric adenocarcinoma | MNDR-E-MI-33397 |
MNDR | hsa-miR-26b-5p | Cervical squamous cell carcinoma | MNDR-E-MI-33398 |
MNDR | hsa-miR-26b-5p | Pituitary adenoma | MNDR-E-MI-33399 |
MNDR | hsa-miR-26b-5p | Lung squamous cell carcinoma | MNDR-E-MI-33400 |
MNDR | hsa-miR-26b-5p | Non-small cell lung adenocarcinoma | MNDR-E-MI-33401 |
MNDR | hsa-miR-26b-5p | Lung adenocarcinoma | MNDR-E-MI-33402 |
MNDR | hsa-miR-26b-5p | Thyroid carcinoma | MNDR-E-MI-33403 |
MNDR | hsa-miR-26b-5p | Ovarian carcinoma | MNDR-E-MI-33404 |
MNDR | hsa-miR-26b-5p | Carcinoma renal cell | MNDR-E-MI-33405 |
MNDR | hsa-miR-26b-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-33406 |
MNDR | hsa-miR-26b-5p | Renal clear cell carcinoma | MNDR-E-MI-33407 |
MNDR | hsa-miR-26b-5p | Intrahepatic cholangiocarcinoma | MNDR-E-MI-33408 |
MNDR | hsa-miR-26b-5p | Cholangiocarcinoma | MNDR-E-MI-33409 |
MNDR | hsa-miR-26b-5p | Lung small cell carcinoma | MNDR-E-MI-33410 |
MNDR | hsa-miR-26b-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-33411 |
MNDR | hsa-miR-26b-5p | T acute lymphoblastic leukemia | MNDR-E-MI-33412 |
MNDR | hsa-miR-26b-5p | Acute t cell leukemia | MNDR-E-MI-33413 |
MNDR | hsa-miR-26b-5p | Acute heart failure | MNDR-E-MI-33414 |
MNDR | hsa-miR-26b-5p | Growth hormone-secreting pituitary adenoma | MNDR-E-MI-33415 |
MNDR | hsa-miR-26b-5p | Early hepatocellular carcinoma | MNDR-E-MI-33416 |
MNDR | hsa-miR-26b-5p | B-cell lymphoma | MNDR-E-MI-33417 |
MNDR | hsa-miR-26b-5p | Rheumatoid arthritis | MNDR-E-MI-33418 |
MNDR | hsa-miR-26b-5p | T-cell leukemia | MNDR-E-MI-33419 |
MNDR | hsa-miR-26b-5p | Neuroblastoma | MNDR-E-MI-33420 |
MNDR | hsa-miR-26b-5p | Barrett's adenocarcinoma | MNDR-E-MI-33421 |
MNDR | hsa-miR-26b-5p | Osteoarthritis | MNDR-E-MI-33422 |
MNDR | hsa-miR-26b-5p | Hodgkin lymphoma | MNDR-E-MI-33423 |
MNDR | hsa-miR-26b-5p | Ulcerative colitis | MNDR-E-MI-33424 |
MNDR | hsa-miR-26b-5p | Burkitt lymphoma | MNDR-E-MI-33425 |
MNDR | hsa-miR-26b-5p | Dementia vascular | MNDR-E-MI-33426 |
MNDR | hsa-miR-26b-5p | Psoriasis | MNDR-E-MI-33427 |
MNDR | hsa-miR-26b-5p | Acute myelocytic leukemia | MNDR-E-MI-33428 |
MNDR | hsa-miR-26b-5p | Colorectal cancer | MNDR-E-MI-33429 |
MNDR | hsa-miR-26b-5p | Nasopharynx carcinoma | MNDR-E-MI-33430 |
MNDR | hsa-miR-26b-5p | Multiple myeloma | MNDR-E-MI-33431 |
MNDR | hsa-miR-26b-5p | Acute lymphocytic leukemia | MNDR-E-MI-33432 |
MNDR | hsa-miR-26b-5p | Ovarian epithelial cancer | MNDR-E-MI-33433 |
MNDR | hsa-miR-26b-5p | Cardiomegaly | MNDR-E-MI-33434 |
MNDR | hsa-miR-26b-5p | Nasopharyngeal cancer | MNDR-E-MI-33435 |
MNDR | hsa-miR-26b-5p | Stroke lacunar | MNDR-E-MI-33436 |
MNDR | hsa-miR-26b-5p | Barrett's carcinogenesis | MNDR-E-MI-33437 |
MNDR | hsa-miR-26b-5p | Breast cancer her3+ negative | MNDR-E-MI-33438 |
MNDR | hsa-miR-26b-5p | High grade dysplastic nodule | MNDR-E-MI-33439 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | ABCA1 | Homo sapiens | RR00022108 |
TOP